Michelle F. Magee

Michelle F. Magee, MD, MBBCh, BAO, LRCPSI

Michelle Magee, MD, Associate Professor of Medicine, Georgetown University School of Medicine and Healthcare Sciences, is a health services researcher, clinician and educator who has been engaged in the conduct of clinical trials and community CVD and DM prevention and education programs among underserved minorities with the MedStar Health Research Institute (MHRI) since 1993.

Dr Magee’s areas of expertise include chronic care initiatives targeting diabetes and CVD primary and secondary prevention.  She has experience on NIH grants having served as a sub-investigator for the NIH Diabetes Prevention Program (DPP) and Women’s Health Initiative Studies MHRI sites in DC, and as Diabetes Principal Investigator for the NIH BARI 2D Trial MHRI site at Washington-Hospital Center-Georgetown University Hospital. She has conducted multiple initiatives in collaboration with and funded by the District of Columbia Department of Health and with Pharma support for Investigator Initiated Trials.  These projects predominantly address provision of DM and CVD guideline-driven medical and self-management education services and prevention of recurrent visits to the Emergency Department for uncontrolled diabetes among underserved majority African American DC residents with or at risk for diabetes and CVD.

In her role as Director of the Medstar Diabetes Institute Dr Magee oversees clinical, education and research programs for the 10 hospital MedStar Health System and serves as a member of the MHRI IRB and as Chair of the MHRI Research Development Council.  She is actively engaged in hospital glycemic management initiatives both within the MedStar system and at a national level with the Society of Hospital Medicine and the PRIDE group. She has expertise in the health information technology space and has been responsible for the development and early implementation of a web-based, patient-centric, Personal Health Record platform (eHealth2go) which is being offered to high-risk, vulnerable and minority DC residents with chronic diseases to enable self-management and communication of personal health information across the spectrum of care.  Finally, she serves on national committees (see positions below) which provide input into clinical management and QI programs for diabetes and cardiovascular disease. She was a member of the American Diabetes Association Professional Practice Committee which prepared the 2011 and 2012 ADA Standards of Medical Care for Diabetes and now serves on the ADA Research Policy Committee.